Name of opportunity: 👀
Merck & Co, Inc
Makers of the world’s best selling drug: 💵
Merck is the company behind Keytruda, the top selling prescription drug in the world. Keytruda is a treatment for multiple types of cancer, particularly lung cancer. In Merck’s second quarter earnings, the company revealed that Keyruda sales (US$7.3 billion) were up 16% from the previous year, which is a striking increase. While the drug’s patent will expire in 2028, meaning that other manufacturers will be free to make their own generic versions, until then every prescription of Keytruda will make Merck - and by extensive its shareholders - money.
How hot is this investment opportunity? 🔥🔥🔥
Analysts predict the price of Merck & Co. Inc. will increase from $117.10 to $142.90 in the next 12 months. If you invested $1000, you might profit $206.38 - which would not be a bad profit at all!
Merck is currently up 4.62% from where it was a month ago, as it is recovering from a dip. Its shares fell at the end of July when the company disappointed analysts with a lower than expected forecast for the rest of the year. Having fallen by 10% initially, Merck now seems to be on the up again. This could be an opportunity to grab this stock at a lower price than usual.
One reason the price of the stock is predicted to increase is because Merck has a range of drugs at various stages in the pipeline that could be incredibly successful - designed to treat other forms of cancer, as well as many different conditions. Merck’s new drug Winrevair was also recently approved to treat people with pulmonary arterial hypertension (PAH), a type of high blood pressure.
Another reason this could be a good addition to your portfolio is that Merck has increased its dividend payouts by 75% over the past ten years. Right now, the company currently offers a 2.57% dividend yield, paying $3.04 per share in the last 12 months. If you invested $1000, you would be paid $25.70 a year in dividends.
Pharma: 🏥
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, including biological therapies, vaccines and animal health products. With the huge success of Keytruda, part of Merck’s focus is on developing other cancer drugs.
Which neme?: 🔍
‘Pharma’
Download Nemo to check out Merck
